EmployblEmploybl logo
employbl
Cleave Therapeutics logo

Cleave Therapeutics Funding & Investors

San Francisco, CA

Cleave Therapeutics is a biopharmaceutical company focused on valosin-containing protein (VCP)/p97 as a novel target in protein homeostasis and cellular stress pathways for therapeutic use in cancer and neurodegenerative diseases.

cleavetherapeutics.com

Total Amount Raised: $101,000,000

Cleave Therapeutics Funding Rounds

  • Series C

    $12,000,000

    Series C Investors

    5am Ventures
    Arcus Ventures
    Astellas Venture Management
    Celgene
    OrbiMed Advisors
    OUP (Osage University Partners)
    U.S. Venture Partners (USVP)

  • Series B

    $37,000,000

    Series B Investors

    NEA - New Enterprise Associates
    Nextech Invest
    Celgene
    Arcus Ventures
    5am Ventures
    Clarus Ventures
    OrbiMed Advisors
    U.S. Venture Partners (USVP)
    Astellas Venture Management
    OUP (Osage University Partners)

  • Series A

    $10,000,000

    Series A Investors

    NEA - New Enterprise Associates

  • Series A

    $42,000,000

    Series A Investors

    5am Ventures
    Clarus Ventures
    OrbiMed Advisors
    U.S. Venture Partners (USVP)
    Astellas Venture Management
    OUP (Osage University Partners)
Funding info provided by Diffbot.